These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8351686)

  • 21. Prevalence and methodology of patch testing by allergists in the United States: results of a cross-sectional survey.
    Farrell AL; Warshaw EM; Zhao Y; Nelson D
    Am J Contact Dermat; 2002 Dec; 13(4):157-63. PubMed ID: 12478529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peculiarities of patch testing in children].
    Vigan M
    Ann Dermatol Venereol; 2009; 136(8-9):617-20. PubMed ID: 19686898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004.
    Zug KA; McGinley-Smith D; Warshaw EM; Taylor JS; Rietschel RL; Maibach HI; Belsito DV; Fowler JF; Storrs FJ; DeLeo VA; Marks JG; Mathias CG; Pratt MD; Sasseville D
    Arch Dermatol; 2008 Oct; 144(10):1329-36. PubMed ID: 18936397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patch test results with metals and meteorological conditions.
    Hegewald J; Uter W; Kranke B; Schnuch A; Gefeller O; Pfahlberg A
    Int Arch Allergy Immunol; 2008; 147(3):235-40. PubMed ID: 18594154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patch testing: pitfalls and performance.
    Mowad CM
    Curr Opin Allergy Clin Immunol; 2006 Oct; 6(5):340-4. PubMed ID: 16954787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of patch testing children with atopic dermatitis.
    Vender RB
    Skin Therapy Lett; 2002 Jun; 7(6):4-6. PubMed ID: 12223977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single doses of local betamethasone do not suppress allergic patch test reactions to nickel sulfate.
    Molander G; Petman L; Kannas L; Lauerma AI
    Contact Dermatitis; 2004 Apr; 50(4):218-21. PubMed ID: 15186376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis.
    Rajagopalan R; Anderson R
    Am J Contact Dermat; 1997 Dec; 8(4):215-21. PubMed ID: 9417366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of previously patch-tested patients referred to a contact dermatitis clinic.
    Soni BP; Sherertz EF
    Am J Contact Dermat; 1997 Mar; 8(1):10-4. PubMed ID: 9066841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reimbursement for patch testing at academic centers: the Achilles' heel of academic contact dermatitis specialists.
    Warshaw EM
    Am J Contact Dermat; 2003 Dec; 14(4):215-6. PubMed ID: 14738724
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphocyte transformation test in patients with allergic contact dermatitis.
    Basketter D; Menné T
    Contact Dermatitis; 2005 Jul; 53(1):1. PubMed ID: 15982223
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphocyte proliferation testing in chromium allergic contact dermatitis.
    Martins LE; Duarte AJ; Aoki V; Nunes RS; Ogusuku S; Reis VM
    Clin Exp Dermatol; 2008 Jul; 33(4):472-7. PubMed ID: 18582233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [How to test occupational products brought in by patients].
    Geraut C; Belli M; Geraut L; Tripodi D
    Ann Dermatol Venereol; 2009; 136(8-9):600-1. PubMed ID: 19686894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scratch-patch test for the diagnosis of allergic contact dermatitis to aciclovir.
    Nino M; Balato N; Di Costanzo L; Gaudiello F
    Contact Dermatitis; 2009 Jan; 60(1):56-7. PubMed ID: 19125724
    [No Abstract]   [Full Text] [Related]  

  • 35. Patterns of cosmetic contact allergy.
    Castanedo-Tardan MP; Zug KA
    Dermatol Clin; 2009 Jul; 27(3):265-80, vi. PubMed ID: 19580921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Skin testing with cosmetics brought in by patients].
    Pons-Guiraud A
    Ann Dermatol Venereol; 2009; 136(8-9):596-9. PubMed ID: 19686893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patch testing with metalworking fluids from the patient's workplace.
    Geier J; Uter W; Lessmann H; Frosch PJ
    Contact Dermatitis; 2004 Oct; 51(4):172-9. PubMed ID: 15500666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patch testing reactions to a standard series in 608 patients tested from 1990 to 1997 at Massachusetts General Hospital.
    Albert MR; González S; González E
    Am J Contact Dermat; 1998 Dec; 9(4):207-11. PubMed ID: 9810020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audit of primary and secondary care as a source of patch test clinic referrals.
    Lamb SR; Wilkinson SM
    Br J Dermatol; 2004 Dec; 151(6):1258-60. PubMed ID: 15606523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patch testing: another steroid-sparing agent to consider in children.
    Jacob SE; Burk CJ; Connelly EA
    Pediatr Dermatol; 2008; 25(1):81-7. PubMed ID: 18304161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.